people with and without dementia. The influence of organic brain changes, cerebrovascular and other somatic diseases, cognitive function, and comorbidity may be especially relevant among the elderly. Finally, survival into old age increases, worldwide. This will result in more people with psychiatric disorders surviving with their disorder into old age. Little research has been done on how aging shapes the clinical expression of psychiatric diseases. For example, it is often suggested that manic episodes become less common with age in patients with bipolar disorders, or that panic attacks disappear in those with panic disorders.
Another special aspect in the management of elderly people with psychiatric disorders is related to pharmacological treatment. First, the elderly are more at risk for adverse side effects owing to slower metabolism and other age-related pharmacokinetic and pharmacodynamic changes. Thus they may not tolerate doses that are commonly used in younger patients. Conversely, interindividual differences increases with age, and many elderly people are treated with toolow doses owing to the concern for side effects. Second, multipharmacology is common in the elderly, which may lead to dangerous interactions. Third, side effects not reported in younger age groups may appear in the elderly and people with dementia. One example is the increased risk for stroke and premature death related to neuroleptic drug use in people with dementia. Fourth, the elderly have more comorbid somatic conditions, which may affect treatment. Despite all these factors, trials are seldom executed in the elderly, and results from trials in younger age groups may not be relevant in trials of the elderly. Further, exclusion criteria normally used in drug trials may result in the selection of patient groups that are not representative of elderly patients. Finally, all doctors concerned with the elderly, including psychiatrists, need to evaluate cognitive function in their W La Revue canadienne de psychiatrie, vol 56, no 7, juillet 2011
Guest Editorial elderly patients, as it may have implications for drug adherence. Impaired cognitive function does not necessarily point to a diagnosis of dementia, as most psychiatric disorders in the elderly give rise to cognitive symptoms.
The relation between psychiatric disorders and dementia is complex. Psychiatric disorders may be prodromes or risk factors for dementing disorders, but dementia also increases the risk for psychiatric symptoms. The common belief that psychiatric disorders in the elderly are almost always related to organic brain changes and dementia is a large exaggeration. As mentioned in this issue, 5 most symptoms of depression, anxiety, and psychosis in the elderly, even when it occurs for the first time during late life, is not a prodrome of dementia. However, psychiatric symptoms are common in people with dementia, occurring in about two-thirds of patients. The nosology of psychiatric manifestations in people with dementia is controversial, and a battle between lumpers and splitters. The dominating term, in research as well as in clinical practice, is behavioural and psychological symptoms of dementia (commonly referred to as BPSD), which comprises almost every psychiatric and behavioural manifestation in people with dementia. This entity has been the target of treatment in many trials, an approach that could be questioned. As noted by Dr Ravi Bhat and Dr Kenneth Rockwood, 6 it is unrealistic to believe that one drug should improve all psychiatric symptoms in people with dementia. It is also unrealistic to believe that all psychiatric symptoms of dementia should have the same pathogenesis and risk factors. Conversely, the different manifestations are also often described in terms of individual symptoms. At the present stage of knowledge, this may be the best approach, both in relation to research and to clinical management. It may even be best to study the phenomenology of these symptoms, as their presentation may differ from that generally described in psychiatry. Very few studies use the syndromatic approach of the Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, or the International Classification of Diseases, 10th Edition, for psychiatric disorders in people with dementia, probably owing to a belief that these are not applicable in this patient group.
One aspect of psychiatric disorders in relation to nosological entities, among people both with and without dementia, and in all ages, is the large overlap in symptoms and syndromes between psychiatric disorders. This comorbidity is a challenge to current diagnostic entities, but also gives rise to speculations regarding pathogenetic mechanisms. Comorbidity may be both concurrent and nonconcurrent; that is, patients may shift between diagnoses during their lifetime. It is well known that people with one psychiatric disorder have an increased risk for developing another psychiatric disorder during their life. The longer the lifespan, the larger the risk for another psychiatric disorder, a fact that obviously is relevant in the elderly.
Thus there is a need to increase knowledge among psychiatrists regarding the geriatric aspects of psychiatric disorders. This has implications not only for the management of elderly patients in clinical practice but also for our understanding of psychiatric disorders in general, from a life-course perspective, and from the interaction with organic and social factors evolving during aging.
